InvestorsHub Logo

Jesspro

05/25/21 12:34 PM

#12791 RE: Ganz #12790

been hinting that even a year ago. They have a lot to lose if another big pharma acquires it. It will not come cheap because of Voclosporin’s potential and the 16 more years of patent ownership. This is a no- brainer.